About
Acies Bio is a leading European biotech CDMO company specializing in the development of innovative and complete solutions across microbial biotechnology, synthetic biology and precision fermentation.
With nearly 20 years of experience and a team of over 100 scientists, Acies Bio has developed numerous industrial technologies and bioprocesses through our SmartRoute platform, which streamlines the execution of projects from ideation to production. Our expertise lies in leveraging our integrated, end-to-end R&D capabilities, proprietary chassis strains, and efficient project management.
Core activities include algorithm-supported strain design and media development, automated microfluidics-supported ultra-high throughput strain selection and optimization of precision fermentation processes, and isolation of final products. With extensive experience in bioprocess development from small-scale bioreactors to large-scale bioprocesses (10 m3) coupled with on-site downstream processing, our pilot facility is ideal for scale-up studies of diverse industrial bioprocesses.
Acies Bio has so far supported more than 90 industrial partners and customers from diverse market segments, including agriculture, food & feed, biomaterials, pharma, and chemicals & pharmaceuticals segments.
